The Latest in Rare Diseases

Neurology Reviews

The dawning age of therapy for Friedreich ataxia

October 13, 2023

Neurology Reviews

2023 Rare Neurological Disease Special Report

October 13, 2023

Rare Diseases

Neurology Reviews

Advances in testing and therapeutics are improving the lives of patients with Fabry disease

October 13, 2023

Rare Diseases

Neurology Reviews

Guillain-Barré syndrome: Honing treatment strategies

October 13, 2023

Rare Diseases

Neurology Reviews

The Orphan Drug Act and NORD at their 40th anniversary: Dramatic achievements and ongoing innovation

October 13, 2023

Rare Diseases

Neurology Reviews

Emerging therapies in Duchenne and facioscapulohumeral muscular dystrophy

October 13, 2023

Neurology Reviews

Has prompt diagnosis of amyotrophic lateral sclerosis become urgent?

October 13, 2023

Neurology Reviews

West Nile infections rising in the U.S.

August 15, 2023

Rare Diseases

Neurology Reviews

Gene therapy promising for reversal of hereditary vision loss

July 14, 2023

Rare Diseases

Neurology Reviews

Myasthenia gravis drug gets FDA nod

June 27, 2023

Neurology Reviews

Can a repurposed Parkinson’s drug slow ALS progression?

June 22, 2023

Neurology Reviews

FDA OKs new drug for Fabry disease

May 11, 2023

Rare Diseases

Neurology Reviews

U.S. incidence, prevalence of myasthenia gravis is rising

May 3, 2023

Neurology Reviews

FDA gives fast-track approval to new ALS drug

April 27, 2023

Rare Diseases

Neurology Reviews

Study compares noninvasive treatments of cutaneous neurofibromas

April 15, 2023

Rare Diseases